GeneDx Holdings Corp. Other Nonoperating Income (Expense)
GeneDx Holdings Corp. (WGS) reported Other Nonoperating Income (Expense) of $162.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-03
- GeneDx Holdings Corp. other nonoperating income (expense) for the quarter ending 2026-06-30 was $162.00K, a 32.22% decline year-over-year.
- GeneDx Holdings Corp. other nonoperating income (expense) for the quarter ending 2026-03-31 was -$206.00K, a 198.56% decline year-over-year.
- GeneDx Holdings Corp. other nonoperating income (expense) for the quarter ending 2025-12-31 was -$4.59M.
- GeneDx Holdings Corp. other nonoperating income (expense) for the quarter ending 2025-09-30 was -$174.00K, a 115.21% decline year-over-year.
- GeneDx Holdings Corp. other nonoperating income (expense) for fiscal 2025 was -$4.32M.
- GeneDx Holdings Corp. other nonoperating income (expense) for fiscal 2024 was -$13.01M, a 903.83% decline from fiscal 2023.
- GeneDx Holdings Corp. other nonoperating income (expense) for fiscal 2023 was $1.62M, a 2740.35% increase from fiscal 2022.
- GeneDx Holdings Corp. other nonoperating income (expense) for fiscal 2022 was $57.00K, a 98.89% decline from fiscal 2021.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 3 month as first filed | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 6 month as first filed | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $162.00K 10-Q · filed 2026-08-03 | -$44.00K 10-Q · filed 2026-08-03 | -$4.63M derived: sum of 3 quarters · filed 2026-08-03 | -$4.81M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2026-03-31 | -$206.00K 10-Q · filed 2026-05-04 | -$4.80M derived: sum of 2 quarters · filed 2026-05-04 | -$4.97M derived: sum of 3 quarters · filed 2026-05-04 | -$4.73M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-12-31 | -$4.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$4.76M derived: sum of 2 quarters · filed 2026-02-23 | -$4.53M derived: sum of 3 quarters · filed 2026-08-03 | -$4.32M 10-K · filed 2026-02-23 | ||
| 2025-09-30 | -$174.00K 10-Q · filed 2025-10-28 | $65.00K derived: sum of 2 quarters · filed 2026-08-03 | $274.00K 10-Q · filed 2025-10-28 | -$440.00K derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-06-30 | $239.00K 10-Q · filed 2026-08-03 | $448.00K 10-Q · filed 2026-08-03 | -$266.00K derived: sum of 3 quarters · filed 2026-08-03 | $878.00K derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-03-31 | $209.00K 10-Q · filed 2026-05-04 | -$505.00K derived: sum of 2 quarters · filed 2026-05-04 | $639.00K derived: sum of 3 quarters · filed 2026-05-04 | -$12.84M derived: sum of 4 quarters · filed 2026-05-04 | ||
| 2024-12-31 | -$714.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $430.00K derived: sum of 2 quarters · filed 2026-02-23 | -$13.05M derived: sum of 3 quarters · filed 2026-02-23 | -$13.01M 10-K · filed 2026-02-23 | ||
| 2024-09-30 | $1.14M 10-Q · filed 2025-10-28 | -$12.34M derived: sum of 2 quarters · filed 2025-10-28 | -$12.30M 10-Q · filed 2025-10-28 | -$12.35M derived: sum of 4 quarters · filed 2026-02-23 | ||
| 2024-06-30 | -$13.48M 10-Q · filed 2025-07-29 | -$13.44M 10-Q · filed 2025-07-29 | -$13.49M derived: sum of 3 quarters · filed 2026-02-23 | -$14.63M derived: sum of 4 quarters · filed 2026-02-23 | ||
| 2024-03-31 | $37.00K 10-Q · filed 2025-04-30 | -$12.00K derived: sum of 2 quarters · filed 2026-02-23 | -$1.15M derived: sum of 3 quarters · filed 2026-02-23 | -$1.06M derived: sum of 4 quarters · filed 2026-02-23 | ||
| 2023-12-31 | -$49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$1.18M derived: sum of 2 quarters · filed 2026-02-23 | -$1.10M derived: sum of 3 quarters · filed 2026-02-23 | $1.62M 10-K · filed 2026-02-23 | ||
| 2023-09-30 | -$1.13M 10-Q · filed 2024-10-29 | -$1.05M derived: sum of 2 quarters · filed 2024-10-29 | $1.67M 10-Q · filed 2024-10-29 | $1.67M derived: sum of 4 quarters · filed 2024-10-29 | ||
| 2023-06-30 | $86.00K 10-Q · filed 2024-07-30 | $2.80M 10-Q · filed 2024-07-30 | $2.80M derived: sum of 3 quarters · filed 2024-07-30 | $2.80M derived: sum of 4 quarters · filed 2024-07-30 | ||
| 2023-03-31 | $2.72M 10-Q · filed 2024-04-29 | $2.71M derived: sum of 2 quarters · filed 2024-04-29 | $2.72M derived: sum of 3 quarters · filed 2024-04-29 | $2.77M derived: sum of 4 quarters · filed 2024-04-29 | ||
| 2022-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $1.00K derived: sum of 2 quarters · filed 2024-02-23 | $57.00K derived: sum of 3 quarters · filed 2024-02-23 | $57.00K 10-K · filed 2024-02-23 | ||
| 2022-09-30 | $2.00K 10-Q · filed 2023-11-03 | $58.00K derived: sum of 2 quarters · filed 2023-11-03 | $58.00K 10-Q · filed 2023-11-03 | $108.00K derived: sum of 4 quarters · filed 2023-11-03 | ||
| 2022-06-30 | $56.00K 10-Q · filed 2023-08-08 | $56.00K 10-Q · filed 2023-08-08 | $106.00K derived: sum of 3 quarters · filed 2023-08-08 | -$414.00K derived: sum of 4 quarters · filed 2023-08-08 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | $50.00K derived: sum of 2 quarters · filed 2023-05-09 | -$470.00K derived: sum of 3 quarters · filed 2023-05-09 | -$470.00K derived: sum of 4 quarters · filed 2023-05-09 | ||
| 2021-12-31 | $50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$470.00K derived: sum of 2 quarters · filed 2023-03-16 | -$470.00K derived: sum of 3 quarters · filed 2023-03-16 | $5.11M 10-K · filed 2023-03-16 | ||
| 2021-09-30 | -$520.00K 10-Q · filed 2022-11-14 | -$520.00K derived: sum of 2 quarters · filed 2022-11-14 | $5.06M 10-Q · filed 2022-11-14 | $5.04M derived: sum of 4 quarters · filed 2023-03-16 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-15 | $14.29M 10-Q · filed 2021-07-21 | $5.58M 10-Q · filed 2022-08-15 | -$42.34M 10-Q · filed 2021-07-21 | $5.56M derived: sum of 3 quarters · filed 2023-03-16 | $5.54M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-03-31 | $5.58M 10-Q · filed 2022-05-12 | $5.56M derived: sum of 2 quarters · filed 2023-03-16 | $5.54M derived: sum of 3 quarters · filed 2023-03-16 | |||
| 2020-12-31 | -$23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$49.00K derived: sum of 2 quarters · filed 2023-03-16 | $2.62M 10-K · filed 2023-03-16 | |||
| 2020-09-30 | -$26.00K 10-Q · filed 2021-11-15 | $2.65M 10-Q · filed 2021-11-15 | ||||
| 2019-12-31 | $504.00K 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |